One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Ophthalmology PACS (Picture Archiving and Communication System) Market

[ 英語タイトル ] Ophthalmology PACS (Picture Archiving and Communication System) Market by Type (Standalone, Integrated), Delivery (On-premise, Cloud), End User (Hospitals, Specialty Clinic, ASC), Region (North America (US, Canada) Europe, Asia) - Global Forecast to 2023


Product Code : MNMHC00110110
Survey : MarketsandMarkets
Publish On : March, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

“The global ophthalmology PACS market is projected to grow at 8.5% during the forecast period.”

The global ophthalmology PACS market is projected to reach USD 160.2 million by 2023 from an estimated USD 106.6 million in 2018, at a CAGR of 8.5% during the forecast period. Growth in this market is mainly driven by the rapid growth in the geriatric population, rising prevalence of eye diseases, limited number of ophthalmologists, government initiatives to encourage the adoption of EHR/EMR, and the increasing adoption of teleophthalmology. On the other hand, high implementation and maintenance costs are expected to limit market growth during the forecast period. Poor compatibility with informatics standards may also challenge market growth to a certain extent.

“By delivery model, web/cloud-based models are expected to grow at the highest CAGR during the forecast period.”
On the basis of delivery model, the ophthalmology PACS market is segmented into on-premise and web/cloud-based models. The web/cloud-based PACS segment is expected to grow at the highest CAGR during the forecast period. Cloud-based models do not incur any major setup charges. Additionally, the maintenance and support service charges are also inclusive of the subscription fees, making these delivery modes more affordable for customers.
“Asia to witness high growth during the forecast period.”
In 2018, North America is expected to account for the largest share of the market followed by Europe. However, Asia is expected to grow at the highest CAGR during the forecast period. The high growth of this regional segment is attributed to the increasing demand for diagnostic imaging procedures, growing medical tourism, increasing geriatric population and incidence of age-related eye diseases, growing awareness on healthcare services, rising healthcare expenditure, and developing healthcare infrastructure.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 30%; Tier 2 - 42%; Tier 3 - 28%.
• By Designation: C-level- 25%; D-level- 45%; others--30%.
• By Region: North America-34%; Europe-28%; Asia -32%; RoW-6%.
List of companies profiled in the report
• Carl Zeiss Meditec AG (Germany)
• Topcon Corporation (Japan)
• Heidelberg Engineering (Germany)
• Sonomed Escalon (US)
• Visbion (UK)
• EyePACS (US)
• IBM Corporation (Merge Healthcare) (US)
• VersaSuite (US)
• Medical Standard (South Korea)
• ScImage (US)
Research Coverage:
The report provides an overview of the ophthalmology PACS market. It aims at estimating the market size and growth potential of this market across different segments such as type, delivery model, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in the ophthalmology PACS market by providing them with the closest approximations of revenues for the overall market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies adopt suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.
 

TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 17
1.3.1 YEARS CONSIDERED FOR THE STUDY 17
1.3.2 MARKETS COVERED 17
1.4 CURRENCY 18
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DATA 19
2.1.1 SECONDARY DATA 20
2.1.1.1 Key data from secondary sources 20
2.1.2 PRIMARY DATA 20
2.1.2.1 Key data from primary sources 21
2.2 MARKET SIZE ESTIMATION 22
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.4 ASSUMPTIONS FOR THE STUDY 24
3 EXECUTIVE SUMMARY 25
4 PREMIUM INSIGHTS 28
4.1 OPHTHALMOLOGY PACS: MARKET OVERVIEW 28
4.2 OPHTHALMOLOGY PACS MARKET, BY TYPE, 2018–2023 28
4.3 OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2018 VS. 2023 (USD MILLION) 29
4.4 OPHTHALMOLOGY PACS MARKET, BY END USER (2018) 29
4.5 GEOGRAPHICAL SNAPSHOT OF THE OPHTHALMOLOGY PACS MARKET 30
5 MARKET OVERVIEW 31
5.1 INTRODUCTION 31
5.2 MARKET DYNAMICS 31
5.2.1 DRIVERS 32
5.2.1.1 Rapid growth in the geriatric population 32
5.2.1.2 Rising prevalence of eye diseases 32
5.2.1.3 Limited number of ophthalmologists 33
5.2.1.4 Government initiatives to encourage adoption of EHR/EMR 33
5.2.1.5 Expansion of teleophthalmology 34

5.2.2 RESTRAINTS 34
5.2.2.1 High implementation and maintenance costs 34
5.2.3 OPPORTUNITIES 35
5.2.3.1 Untapped emerging markets 35
5.2.3.2 Integration with EHR/EMR 35
5.2.3.3 High-growth opportunities represented by cloud-based platforms 36
5.2.4 CHALLENGES 36
5.2.4.1 Poor compatibility with informatics standards 36
6 INDUSTRY INSIGHTS 37
6.1 NEW VS. REPLACEMENT MARKET 37
6.2 PACS VS. VENDOR NEUTRAL PACS 38
6.3 OPHTHALMOLOGISTS VS. OPTOMETRISTS 39
6.4 MARKET ENTRY STRATEGY 39
6.4.1 KEY FUNCTIONALITIES REQUIRED: 40
6.5 LIST OF OPHTHALMOLOGY/OPTOMETRY PRACTICES, BY REGION 40
7 OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL 45
7.1 INTRODUCTION 46
7.2 ON-PREMISE MODEL 47
7.3 WEB/CLOUD-BASED MODELS 49
8 OPHTHALMOLOGY PACS MARKET, BY TYPE 52
8.1 INTRODUCTION 53
8.2 INTEGRATED PACS 54
8.3 STANDALONE PACS 56
9 OPHTHALMOLOGY PACS MARKET, BY END USER 58
9.1 INTRODUCTION 59
9.2 SPECIALTY CLINICS & AMBULATORY SURGICAL CENTERS (ASCS) 60
9.3 HOSPITALS 62
9.4 OTHER END USERS 65
10 OPHTHALMOLOGY PACS MARKET, BY REGION 67
10.1 INTRODUCTION 68
10.2 NORTH AMERICA 69
10.2.1 US 72
10.2.2 CANADA 74

10.3 EUROPE 76
10.3.1 GERMANY 79
10.3.2 FRANCE 80
10.3.3 UK 82
10.3.4 ROE 84
10.4 ASIA 86
10.4.1 JAPAN 88
10.4.2 CHINA 90
10.4.3 INDIA 92
10.4.4 SINGAPORE 93
10.4.5 REST OF ASIA (ROA) 95
10.5 PACIFIC COUNTRIES 96
10.6 REST OF THE WORLD 98
11 COMPETITIVE LANDSCAPE 100
11.1 OVERVIEW 100
11.2 MARKET SHARE ANALYSIS 101
11.3 COMPETITIVE SCENARIO 103
11.3.1 EXPANSIONS (2015–2018) 103
11.3.2 MERGERS AND ACQUISITIONS (2015–2018) 103
11.3.3 PRODUCT LAUNCHES AND ENHANCEMENTS (2015–2018) 104
11.3.4 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS (2015–2018) 105
12 COMPANY PROFILES 106
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
12.1 IBM CORPORATION (MERGE HEALTHCARE INCORPORATED) 106
12.2 CARL ZEISS MEDITEC AG 109
12.3 TOPCON CORPORATION 112
12.4 HEIDELBERG ENGINEERING 115
12.5 SONOMED ESCALON 117
12.6 VISBION 119
12.7 EYEPACS 120
12.8 VERSASUITE 121
12.9 MEDICAL STANDARD 122
12.10 SCIMAGE 123
12.11 AGFA-GEVAERT GROUP 124
12.12 CANON USA, INC. 126
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

13 APPENDIX 128
13.1 INSIGHTS FROM INDUSTRY EXPERTS 128
13.2 DISCUSSION GUIDE 129
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 131
13.4 AVAILABLE CUSTOMIZATIONS 133
13.5 RELATED REPORTS 133
13.6 AUTHOR DETAILS 134

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+